The following excerpt is from franchise expert Mark Siebert’s book The Multiplier Model. Buy it now. When it comes to franchise success, continually striving for improvement is key. In the marketing ...
Pfizer recently announced a major multinational study involving some 20,000 patients to compare the safety of its COX-2 inhibitor Celebrex with over-the-counter painkillers, ibuprofen and naproxen.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results